Recent News

Recent Blog Posts

Where We Are With 2015 Malt Beverage Legislation

  • March 27th, 2015

I have been asked a few times in recent days for a quick update of where things generally stand as we near the halfway point in the 2015 legislative session.  This is that:

Senate Bill 186, filed by […]

Current Investigations

SFX Entertainment
Komlossy Law, P.A. is investigating the Board of Directors of SFX Entertainment, Inc. (“SFX” or the “Company”) (NASDAQ: SFXE) for possible breaches of fiduciary duty and other violations of state law in connection with a proposal from Robert F.X. Sillerman, the Company’s Chief Executive Officer and Executive Chairman of the Board of Directors, to acquire all of the outstanding shares of common stock of the company not already owned by him for $4.75 per share in cash. Sillerman owns nearly 40% of the outstanding common stock of SFX Entertainment.

The investigation relates to whether the proposal is fair to the public stockholders of SFX and whether Sillerman is seeking to take advantage of his insider knowledge with respect to the going private proposal. SFX has traded above the offer price for a large majority of its history as a public company.

If you own SFX stock and wish to obtain additional information about your rights as a shareholder at not cost, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Emulex
Komlossy Law, P.A. is investigating the Board of Directors of Emulex Corporation (“Emulex” or the “Company”) (NYSE: ELX) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Avago Technologies Limited (“Avago”).  Pursuant to the terms of the proposed transaction, Emulex shareholders are to receive $8.00 for each share of the Company.

The investigation involves whether the Board of Directors of Emulex breached its fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Emulex stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. represents shareholders in complex litigation, including class action and derivative litigation.  Komlossy Law, P.A. may co-counsel with another firm, or refer a case to another firm.  More information is available upon request.

Mako
Komlossy Law, P.A. is investigating the Board of Directors of Mako Surgical Corp. (“Mako” or the “Company”) (NASDAQ:MAKO)  for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Stryker Corp. (“Stryker”) in a transaction valued at approximately $1.65 billion.  Pursuant to the terms of the proposed transaction, Mako shareholders are to receive $30.00 for each share of the Company.

The investigation involves whether the Board of Directors of Mako breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Mako stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. represents shareholders in complex litigation, including class action and derivative litigation.  Komlossy Law, P.A. may co-counsel with another firm, or refer a case to another firm.  More information is available through the firm’s website, www.komlossylaw.com, and upon request.  Emily C. Komlossy is the attorney responsible for the content of this release.

Boise
Komlossy Law, P.A. is investigating the Board of Directors of Boise, Inc. (“Boise”) or the “Company”) (NYSE:BZ) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Packaging Corporation of America (“PKG”) in a transaction valued at approximately $1.995 billion.  Pursuant to the terms of the proposed transaction, Boise shareholders are to receive $12.55 for each share of the Company.

The investigation involves whether the Board of Directors of Boise breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the transaction, and whether the transaction is fair to shareholders with respect to price, process and disclosure of all material information.

If you own Boise stock and wish to obtain additional information about your rights as a shareholder, or if you have information about the above investigation, please contact Emily C. Komlossy, Esq. via email at eck@komlossylaw.com or by telephone toll free at (855) 858-1233.

Komlossy Law, P.A. represents shareholders in complex litigation, including class action and derivative litigation.  Komlossy Law, P.A. may co-counsel with another firm, or refer a case to another firm.  More information is available through the firm’s website, www.komlossylaw.com, and upon request.  Emily C. Komlossy is the attorney responsible for the content of this release.

 

Register for Newsletter

Email info@komlossylaw.com to sign up for our newsletter (Subject: Subscribe).

NewsLetter2Cover